Global Duchenne Muscular Dystrophy Drugs Market Set to Reach $ 5.5 Billion by 2032, With a CAGR of 10.17% Driven by New Product Approvals, Launches, and a Favorable Landscape [Yahoo! Finan...
FibroGen, Inc (FGEN)
Last fibrogen, inc earnings: 3/2 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=253783&p=irol-irhome
Company Research
Source: Yahoo! Finance
Market by Product Type, Therapeutic Approach, End User, and Region 2024-2032" report has been added to ResearchAndMarkets.com's offering. The global Duchenne muscular dystrophy (DMD) drugs market is currently experiencing a significant growth period, with projections indicating a climb from US$ 2.3 Billion in 2023 to an impressive US$ 5.5 Billion by the year 2032. This growth is anticipated to occur at a compound annual growth rate (CAGR) of 10.17% over the forecast period, driven by the increasing prevalence of DMD, a range of new product approvals, launches, and a favorable landscape shaped by government initiatives and reimbursement policies conducive to target-specific treatments. A notable trend positively influencing the global market is the surge in new product approvals and launches, which correlates with the rising cases of DMD. Moreover, advancements such as mutation-specific therapies and innovation in diagnostics are pushing the industry forward. Continuous research an
Show less
Read more
Impact Snapshot
Event Time:
FGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FGEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FGEN alerts
High impacting FibroGen, Inc news events
Weekly update
A roundup of the hottest topics
FGEN
News
- FibroGen, Inc. (NASDAQ:FGEN) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- FibroGen to Participate in Upcoming Investor Conferences [Yahoo! Finance]Yahoo! Finance
- FibroGen to Participate in Upcoming Investor ConferencesGlobeNewswire
- FibroGen Reports First Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
- FibroGen Reports First Quarter 2024 Financial ResultsGlobeNewswire
FGEN
Earnings
- 5/6/24 - Miss
FGEN
Sec Filings
- 5/6/24 - Form 10-Q
- 5/6/24 - Form 8-K
- 5/2/24 - Form 4
- FGEN's page on the SEC website